Fredag 27 December | 03:02:29 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-11-14 08:00 Kvartalsrapport 2025-Q3
2025-08-20 08:00 Kvartalsrapport 2025-Q2
2025-05-16 08:00 Kvartalsrapport 2025-Q1
2025-02-21 08:00 Bokslutskommuniké 2024
2024-11-15 - Kvartalsrapport 2024-Q3
2024-08-21 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning PAX 0.00 SEK
2024-05-23 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-11-17 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-25 - X-dag ordinarie utdelning PAX 0.00 SEK
2023-05-24 - Årsstämma
2023-05-24 - Kvartalsrapport 2023-Q1
2023-02-24 - Bokslutskommuniké 2022
2022-11-18 - Kvartalsrapport 2022-Q3
2022-08-24 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning PAX 0.00 SEK
2022-05-25 - Årsstämma
2022-05-25 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-11-19 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-27 - X-dag ordinarie utdelning PAX 0.00 SEK
2021-05-26 - Årsstämma
2021-05-26 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning PAX 0.00 SEK
2020-05-27 - Årsstämma
2020-05-27 - Kvartalsrapport 2020-Q1
2020-02-21 - Bokslutskommuniké 2019
2019-11-21 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-24 - X-dag ordinarie utdelning PAX 0.00 SEK
2019-05-23 - Årsstämma
2019-05-23 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-22 - Kvartalsrapport 2018-Q3
2018-08-30 - Kvartalsrapport 2018-Q2
2018-05-25 - X-dag ordinarie utdelning PAX 0.00 SEK
2018-05-24 - Årsstämma
2018-05-24 - Kvartalsrapport 2018-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Paxman är verksamt inom skalpkylning, som används för patienter som behandlas för cytostatika. Bolagets produkt Paxman Scalp Cooler används för att minimera håravfallet hos patienten under behandlingens gång. Scalp Coolern är en fristående, mobil och eldriven kylenhet som kyler ner patientens hårbotten via en kylmössa. Paxman grundades 1996 och har idag sitt huvudkontor i Karlshamn.
2024-07-03 16:40:00

 Paxman has partnered with Capri Construction 426 LLC to secure this nationwide contract to deliver Paxman Scalp Cooling Systems to the VA's national healthcare network.

The National Oncology Program (NOP) is the home for cancer care at VA. Diagnosing and treating more than 56,000 Veterans annually, NOP is one of the nation's largest integrated providers of oncology services. 126 VA facilities are participating in NPOP, with 18,000 veterans cared for under the program.

This single-award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract awarded to Capri Construction 426 LLC with Paxman as the sole subcontractor, is projected to be worth $2.7 million over the contract period (which has a base year and four option years spanning July 1, 2024, to June 30, 2029) based on quantity estimates provided by the VA, equating to more than 100 Paxman Scalp Cooling Systems and nearly 1,800 scalp cooling kits throughout the 5-year contract period. Capri and Paxman were successful in this contract award against two other qualified offers.

The VA will acquire cooling systems on an as-needed basis when requested at VA facilities. The Paxman Scalp Cooling equipment fulfilled all requirements of an FDA-cleared machine-based system which will be installed in VA infusion clinics to support all eligible Veterans using VA clinics nationwide. 

Paxman is proud to partner with Capri Construction 426 LLC dba Capri Enterprises, a New York-based, nationally certified Service-Disabled, Veteran-Owned Small Business (SDVOSB) that provides procurement and consulting services to the VA to help improve patient experiences and outcomes.

John Blowers, Program Manager, for Capri, commented, “Capri is excited to be able to partner with Paxman to deliver scalp cooling systems to the VA's national healthcare network and provide compassionate care to the heroes these dedicated professionals serve.”

Richard Paxman, CEO said, “This contract, in partnership with Capri, is the first step for Paxman to support the VA and its patients together in managing the important side-effect of chemotherapy-induced alopecia for Veterans with cancer across the United States. The cancer team at the VA utilize the most up-to-date and cutting-edge technology and Paxman is honored to have been chosen as their nationwide scalp cooling provider. We wholeheartedly share their ethos of excellence and our commitment to patient-centered personalized cancer care is at the heart of all we do. Scalp cooling intervention can help to minimize the emotional toll and long-term impact on patients that is associated with chemotherapy-induced hair loss and know that this will have a huge impact on Veterans, while further reinforcing scalp cooling as a signifier of high-quality cancer care.”